American Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $49.3M | Buy |
361,055
+3,335
| +0.9% | +$410K | 2.21% | 20 |
|
|
2026
Q1 | $42.1M | Buy |
357,720
+22,605
| +7% | +$3.16M | 2.26% | 18 |
|
|
2025
Q4 | $54.9M | Sell |
335,115
-1,747
| -0.5% | -$274K | 2.42% | 16 |
|
|
2025
Q3 | $45M | Buy |
336,862
+7,581
| +2% | +$921K | 1.79% | 22 |
|
|
2025
Q2 | $41M | Sell |
329,281
-51,701
| -14% | -$6.58M | 1.7% | 25 |
|
|
2025
Q1 | $48.5M | Sell |
380,982
-2,547
| -0.7% | -$392K | 1.97% | 23 |
|
|
2024
Q4 | $55.2M | Buy |
383,529
+4,495
| +1% | +$645K | 2.06% | 23 |
|
|
2024
Q3 | $56.4M | Buy |
379,034
+42,335
| +13% | +$6.07M | 1.84% | 24 |
|
|
2024
Q2 | $42.4M | Buy |
336,699
+109,389
| +48% | +$17.1M | 1.42% | 26 |
|
|
2024
Q1 | $41.8M | Sell |
227,310
-5,242
| -2% | -$998K | 1.34% | 28 |
|
|
2023
Q4 | $41.8M | Buy |
232,552
+4,253
| +2% | +$662K | 1.43% | 26 |
|
|
2023
Q3 | $36.3M | Sell |
228,299
-102
| -0% | -$16.7K | 1.4% | 24 |
|
|
2023
Q2 | $32.3M | Buy |
228,401
+55,904
| +32% | +$8.96M | 1.12% | 31 |
|
|
2023
Q1 | $29M | Buy |
172,497
+31,746
| +23% | +$5.66M | 1.02% | 31 |
|
|
2022
Q4 | $23.8M | Buy |
140,751
+17,827
| +15% | +$3.23M | 0.93% | 31 |
|
|
2022
Q3 | $23M | Sell |
122,924
-4,763
| -4% | -$1M | 0.91% | 29 |
|
|
2022
Q2 | $20.7M | Buy |
127,687
+12,873
| +11% | +$2.04M | 0.78% | 36 |
|
|
2022
Q1 | $21.6M | Buy |
114,814
+3,662
| +3% | +$696K | 0.64% | 39 |
|
|
2021
Q4 | $29.4M | Sell |
111,152
-858
| -0.8% | -$231K | 0.76% | 37 |
|
|
2021
Q3 | $32.4M | Sell |
112,010
-1,819
| -2% | -$467K | 0.87% | 35 |
|
|
2021
Q2 | $22.7M | Buy |
113,829
+930
| +0.8% | +$180K | 0.64% | 37 |
|
|
2021
Q1 | $21.9M | Buy |
112,899
+3,281
| +3% | +$673K | 0.66% | 38 |
|
|
2020
Q4 | $21M | Buy |
109,618
+616
| +0.6% | +$112K | 0.63% | 36 |
|
|
2020
Q3 | $16.1M | Buy |
109,002
+423
| +0.4% | +$60.5K | 0.59% | 38 |
|
|
2020
Q2 | $13.4M | Sell |
108,579
-2,210
| -2% | -$260K | 0.49% | 39 |
|
|
2020
Q1 | $10.7M | Buy |
110,789
+37,774
| +52% | +$3.65M | 0.52% | 39 |
|
|
2019
Q4 | $6.75M | Buy |
73,015
+350
| +0.5% | +$29.4K | 0.28% | 48 |
|
|
2019
Q3 | $5.57M | Buy |
72,665
+155
| +0.2% | +$13.6K | 0.25% | 50 |
|
|
2019
Q2 | $6.23M | Sell |
72,510
-830
| -1% | -$56.6K | 0.27% | 50 |
|
|
2019
Q1 | $4.33M | Buy |
73,340
+2,665
| +4% | +$153K | 0.2% | 50 |
|
|
2018
Q4 | $3.73M | Buy |
70,675
+960
| +1% | +$56.3K | 0.2% | 51 |
|
|
2018
Q3 | $3.87M | Buy |
+69,715
| New | +$3.59M | 0.17% | 58 |
|
Other funds holding RGEN
UCFA
MC
WA
American Capital Management's RGEN Position: Q2 2026 in Review
American Capital Management increased its Repligen (RGEN) stake by 0.93% in Q2 2026, buying an estimated $410K and bringing the position to 361,055 shares worth $49.3M. The position accounts for 2.21% of the portfolio, ranked #20.
American Capital Management first reported a position in RGEN in Q3 2018 and has held it in 32 quarters since. The position peaked at $56.4M in Q3 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- American Capital Management held 361,055 shares of Repligen worth $49.3M as of Q2 2026.
- American Capital Management bought 3,335 Repligen shares in Q2 2026, an estimated $410K.
- Repligen made up 2.21% of American Capital Management's portfolio in Q2 2026, its #20 holding.
- American Capital Management first reported a position in Repligen in Q3 2018 and has held it in 32 quarters since.
- American Capital Management's Repligen position peaked at $56.4M in Q3 2024.
- 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on American Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.